CXCL1 and hepatocellular carcinoma: In conclusion, our findings have revealed that CXCL1 downregulates the expression of miR-30b-5p, leading to increased expression of ICAM-1, thereby promoting the motility of hepatocellular carcinoma cells (Figure 8).